Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Harrison

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Harm Reduction Journal|April 14, 2023
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crisesKaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, et al.
Patient Preference and Adherence|December 30, 2022
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot StudySophia Dobischok, Rebecca K Metcalfe, Elizabeth Angela Matzinger, et al.
Nature Methods|January 12, 2016
Predictable tuning of protein expression in bacteriaMads T Bonde, Margit Pedersen, Michael S Klausen, et al.
BMC Health Services Research|May 26, 2023
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative studyEugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, et al.
Addiction (Abingdon, England)|March 29, 2018
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trialNick Bansback, Daphne Guh, Eugenia Oviedo-Joekes, et al.
Journal of Substance Abuse Treatment|June 9, 2019
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periodsEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.
Journal of Hazardous Materials|February 21, 2025
Nanoparticulate and colloidal uranium and plutonium in spent nuclear fuel storage pond effluentsThomas S Neill, Katherine Morris, Scott Harrison, et al.
Substance Abuse Treatment, Prevention, and Policy|May 21, 2017
Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorderHeather Palis, Kirsten Marchand, Daphne Guh, et al.
JAMA Psychiatry|April 7, 2016
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical TrialEugenia Oviedo-Joekes, Daphne Guh, Suzanne Brissette, et al.
Drug and Alcohol Review|June 9, 2017
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependenceEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Harm Reduction Journal|April 14, 2023
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crisesKaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, et al.
Patient Preference and Adherence|December 30, 2022
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot StudySophia Dobischok, Rebecca K Metcalfe, Elizabeth Angela Matzinger, et al.
Nature Methods|January 12, 2016
Predictable tuning of protein expression in bacteriaMads T Bonde, Margit Pedersen, Michael S Klausen, et al.
BMC Health Services Research|May 26, 2023
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative studyEugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, et al.
Addiction (Abingdon, England)|March 29, 2018
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trialNick Bansback, Daphne Guh, Eugenia Oviedo-Joekes, et al.
Journal of Substance Abuse Treatment|June 9, 2019
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periodsEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.
Journal of Hazardous Materials|February 21, 2025
Nanoparticulate and colloidal uranium and plutonium in spent nuclear fuel storage pond effluentsThomas S Neill, Katherine Morris, Scott Harrison, et al.
Substance Abuse Treatment, Prevention, and Policy|May 21, 2017
Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorderHeather Palis, Kirsten Marchand, Daphne Guh, et al.
JAMA Psychiatry|April 7, 2016
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical TrialEugenia Oviedo-Joekes, Daphne Guh, Suzanne Brissette, et al.
Drug and Alcohol Review|June 9, 2017
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependenceEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.
Pageof 7